Albumin has a long half-life and, by binding to the albumin-specific receptor, nab-paclitaxel can accumulate in the tumor more effectively than paclitaxel by an enhanced permeability and retention (EPR) effect [31]. This evidence concerns the gene ALB and neoplasm.